This white paper analyses the current state of chimeric antigen receptor (CAR) T-cell therapy in Australia, expected opportunities and our healthcare system’s preparedness for delivering CAR T-cell therapy at scale.

This report argues for the establishment of an Australian Centre for Disease Control - to bring together the various elements of health protection and promotion into one organisation.

This white paper highlights the most significant obstacles to accessing radiotherapy cancer care in Australia including access, awareness, and financial burden; and provides three evidence-based recommendations to improve utilisation of radiotherapy and health outcomes for Australians living with cancer.